Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONStandard

FLUTICASONE PROPIONATE

FLUTICASONE PROPIONATE

Standard Dose
0.044MG/INH
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FLUTICASONE PROPIONATE is listed in Drugs@FDA under application 219602 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FLUTICASONE PROPIONATE Form and strength AEROSOL, METERED;INHALATION - 0.044MG/INH Sponsor GLENMARK SPECLT Submission history Latest submission status date: 2026-03-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview FLUTICASONE PROPIONATE is listed in Drugs@FDA under application 219602 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FLUTICASONE PROPIONATE Form and strength AEROSOL, METERED;INHALATION - 0.044MG/INH Sponsor GLENMARK SPECLT Submission history Latest submission status date: 2026-03-03 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.